Safety of Intraoperative Cell Salvage in Cancer Surgery: An Updated Meta-Analysis of the Current Literature

Transfusion Medicine and Hemotherapy

Volumn 49, Issue 3, 2022, Pages 143-157

  Frietsch, Thomas ^a   Steinbicker, Andrea U ^b   Horn, Audrey ^c   Metz, Matthes ^d   Dietrich, Gerald ^e   Weigand, Markus A ^f   Waters, Jonathan H ^g   Fischer, Dania ^f  

^a German Interdisciplinary Task Force for Clinical Hemotherapy   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GCP Service International   (Germany)

^e Rottal Inn Kliniken Krankenhaus Eggenfelden   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Autologous transfusion; Cancer recurrence; Cell salvage; Tumor surgery

Indexed keywords

ADULT; BLOOD AUTOTRANSFUSION; BLOOD CELL; BLOOD TRANSFUSION; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FILTRATION; HOSPITALIZATION; HUMAN; HUMAN CELL; MALE; MEDLINE; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURVIVAL; SYSTEMATIC REVIEW; WEB OF SCIENCE;

EID: 85130447204     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000524538     Document Type: Review

References (75)

1. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg. 2012; 256: 235-44.
2. Schneider M, Schafer N, Potthoff AL, Weinhold L, Eichhorn L, Weller J, et al. Perioperative red blood cell transfusion is associated with poor functional outcome and overall survival in patients with newly diagnosed glioblastoma. Neurosurg Rev. 2022; 45: 1327-33.
3. Wu HL, Tai YH, Lin SP, Chan MY, Chen HH, Chang KY. The impact of blood transfusion on recurrence and mortality following colorectal cancer resection: a propensity score analysis of 4,030 patients. Sci Rep. 2018; 8(1): 13345.
4. Liu L, Wang Z, Jiang S, Shao B, Liu J, Zhang S, et al. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a metaanalysis. PLoS One. 2013; 8: e64261.
5. Sun C, Wang Y, Yao HS, Hu ZQ. Allogeneic blood transfusion and the prognosis of gastric cancer patients: systematic review and metaanalysis. Int J Surg. 2015; 13: 102-10.
6. Hanna DN, Gamboa AC, Balch GC, Regenbogen SE, Holder-Murray J, Abdel-Misih SRZ, et al. Perioperative blood transfusions are associated with worse overall survival but not disease-free survival after curative rectal cancer resection: a propensity score-matched analysis. Dis Colon Rectum. 2021; 64(8): 946-54.
7. Isbister JP, Shander A, Spahn DR, Erhard J, Farmer SL, Hofmann A. Adverse blood transfusion outcomes: establishing causation. Transfus Med Rev. 2011; 25: 89-101.
8. Goubran H, Sheridan D, Radosevic J, Burnouf T, Seghatchian J. Transfusion-related immunomodulation and cancer. Transfus Apher Sci. 2017; 56: 336-40.
9. Dickson EA, Acheson AG. Allogeneic blood and postoperative cancer outcomes: Correlation or causation? Anaesthesia. 2020; 75: 438-41.
10. Fischer D, Neb H, Choorapoikayil S, Zacharowski K, Meybohm P. Red blood cell transfusion and its alternatives in oncologic surgerya critical evaluation. Crit Rev Oncol Hematol. 2019; 134: 1-9.
11. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2010; 17: Cd001888.
12. Elmalky M, Yasin N, Rodrigues-Pinto R, Stephenson J, Carroll C, Smurthwaite G, et al. The safety, efficacy, and cost-effectiveness of intraoperative cell salvage in metastatic spine tumor surgery. Spine J. 2017; 17: 977-82.
13. Harrison S, Steele RJ, Johnston AK, Jones JA, Morris DL, Hardcastle JD. Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study. Br J Surg. 1992; 79: 355-7.
14. Valbonesi M, Bruni R, Lercari G, Florio G, Carlier P, Morelli F. Autoapheresis and intraoperative blood salvage in oncologic surgery. Transfus Sci. 1999; 21: 129-39.
15. Frietsch T, Steinbicker AU, Hackbusch M, Nguyen XD, Dietrich G. [Safety of cell salvage in tumor surgery: systematic review with meta- analysis]. Anaesthesist. 2020; 69: 331-51.
16. Connor JP, Morris PC, Alagoz T, Anderson B, Bottles K, Buller RE. Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstet Gynecol. 1995; 86: 373-8.
17. Kinnear N, Heijkoop B, Hua L, Hennessey DB, Spernat D. The impact of intra-operative cell salvage during open radical prostatectomy. Transl Androl Urol. 2018; 7: S179-187.
18. Fujimoto J, Okamoto E, Yamanaka N, Oriyama T, Furukawa K, Kawamura E, et al. Efficacy of autotransfusion in hepatectomy for hepatocellular carcinoma. Arch Surg. 1993; 128: 1065-9.
19. Nutu OA, Sneiders D, Mirza D, Isaac J, Perera MTPR, Hartog H. Safety of intra-operative blood salvage during liver transplantation in patients with hepatocellular carcinoma, a propensity score-matched survival analysis. Transpl Int. 2021; 34(12): 2887-94.
20. Kwon JH, Han S, Kim D, Kuk JH, Cho H, Kim S, et al. Blood salvage and autotransfusion does not increase the risk of tumor recurrence after liver transplantation for advanced hepatocellular carcinoma. Ann Surg. 2021. Online ahead of print.
21. Han S, Kim G, Ko JS, Sinn DH, Yang JD, Joh JW, et al. Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. Ann Surg. 2016; 264: 339-43.
22. Muscari F, Suc B, Vigouroux D, Duffas JP, Migueres I, Mathieu A, et al. Blood salvage autotransfusion during transplantation for hepatocarcinoma: does it increase the risk of neoplastic recurrence? Transpl Int. 2005; 18: 1236-9.
23. Martin RC, Wellhausen SR, Moehle DA, Martin AW, McMasters KM. Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy. Ann Surg Oncol. 2005; 12: 1017-24.
24. Akbulut S, Kayaalp C, Yilmaz M, Ince V, Ozgor D, Karabulut K, et al. Effect of autotransfusion system on tumor recurrence and survival in hepatocellular carcinoma patients. World J Gastroenterol. 2013; 19: 1625-31.
25. Akchurin RS, Davidov MI, Partigulov SA, Brand JB, Shiriaev AA, Lepilin MG, et al. Cardiopulmonary bypass and cell-saver technique in combined oncologic and cardiovascular surgery. Artif Organs. 1997; 21: 763-5.
26. Aning J, Dunn J, Daugherty M, Mason R, Pocock R, Ridler B, et al. Towards bloodless cystectomy: a 10-year experience of intra-operative cell salvage during radical cystectomy. BJU Int. 2012; 110: E608-13.
27. Araujo RL, Pantanali CA, Haddad L, Rocha Filho JA, D'Albuquerque LA, Andraus W. Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence? World J Gastrointest Surg. 2016; 8: 161-8.
28. Bower MR, Ellis SF, Scoggins CR, McMasters KM, Martin RC. Phase ii comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol. 2011; 18: 166-73.
29. Engle DB, Connor JP, Morris PC, Bender DP, De Geest K, Ahmed A, et al. Intraoperative autologous blood transfusion use during radical hysterectomy for cervical cancer: longterm follow-up of a prospective trial. Arch Gynecol Obstet. 2012; 286: 717-21.
30. Davis M, Sofer M, Gomez-Marin O, Bruck D, Soloway MS. The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence? BJU Int. 2003; 91: 474-6.
31. Foltys D, Zimmermann T, Heise M, Kaths M, Lautem A, Wisser G, et al. Liver transplantation for hepatocellular carcinoma - is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res. 2011; 47: 182-7.
32. Gilbert JB, Malkowicz SB, Wein AJ. Cell saver and radical retropubic prostatectomy: analysis of cost-effectiveness. Urology. 1995; 46: 542-4.
33. Gorin MA, Eldefrawy A, Manoharan M, Soloway MS. Oncologic outcomes following radical prostatectomy with intraoperative cell salvage. World J Urol. 2012; 30: 379-83.
34. Gray CL, Amling CL, Polston GR, Powell CR, Kane CJ. Intraoperative cell salvage in radical retropubic prostatectomy. Urology. 2001; 58: 740-5.
35. Hart OJ 3rd, Klimberg IW, Wajsman Z, Baker J. Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder. Surg Gynecol Obstet. 1989; 168: 302-6.
36. Hirano T, Yamanaka J, Iimuro Y, Fujimoto J. Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma. Surg Today. 2005; 35: 1042-6.
37. Ivanics T, Shubert CR, Muaddi H, Claasen MPAW, Yoon P, Hansen BE, et al. Blood cell salvage and autotransfusion does not worsen oncologic outcomes following liver transplantation with incidental hepatocellular carcinoma: a propensity score-matched analysis. Ann Surg Oncol. 2021; 28(11): 6816-25.
38. Kang R, Seath BE, Huang V, Barth RJ Jr. Impact of autologous blood transfusion on survival and recurrence among patients undergoing partial hepatectomy for colorectal cancer liver metastases. J Am Coll Surg. 2019; 228: 902-8.
39. Kim JM, Kim GS, Joh JW, Suh KS, Park JB, Ko JS, et al. Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int. 2013; 26: 84-9.
40. Kinnear N, Hua L, Heijkoop B, Hennessey D, Spernat D. The impact of intra-operative cell salvage during open nephrectomy. Asian J Urol. 2019; 6: 346-52.
41. Lyon TD, Ferroni MC, Turner RM 2nd, Jones C, Jacobs BL, Davies BJ. Short-term outcomes of intraoperative cell saver transfusion during open partial nephrectomy. Urology. 2015; 86: 1153-8.
42. MacIvor D, Nelson J, Triulzi D. Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy. Transfusion. 2009; 49: 1431-4.
43. Mirhashemi R, Averette HE, Deepika K, Estape R, Angioli R, Martin J, et al. The impact of intraoperative autologous blood transfusion during type iii radical hysterectomy for early-stage cervical cancer. Am J Obstet Gynecol. 1999; 181: 1310-6; discussion 1315-6.
44. Myrga JM, Ayyash OM, Bandari J, Fam MM, Macleod LC, Jacobs BL, et al. The safety and short-term outcomes of leukocyte depleted autologous transfusions during radical cystectomy. Urology. 2020; 135: 106-10.
45. Nieder AM, Carmack AJ, Sved PD, Kim SS, Manoharan M, Soloway MS. Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. Urology. 2005; 65: 730-4.
46. Nieder AM, Manoharan M, Yang Y, Soloway MS. Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology. 2007; 69: 881-4.
47. Park KI, Kojima O, Tomoyoshi T. Intra-operative autotransfusion in radical cystectomy. Br J Urol. 1997; 79: 717-21.
48. Pinto MA, Grezzana-Filho TJM, Chedid AD, Leipnitz I, Prediger JE, Alvares-da-Silva MR, et al. Impact of intraoperative blood salvage and autologous transfusion during liver transplantation for hepatocellular carcinoma. Langenbecks Arch Surg. 2021; 406(1): 67-74.
49. Pisters LL, Wajsman Z. Use of predeposit autologous blood and intraoperative autotransfusion in urologic cancer surgery. Urology. 1992; 40: 211-5.
50. Raval JS, Nelson JB, Woldemichael E, Triulzi DJ. Intraoperative cell salvage in radical prostatectomy does not appear to increase longterm biochemical recurrence, metastases, or mortality. Transfusion. 2012; 52: 2590-3.
51. Stoffel JT, Topjian L, Libertino JA. Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU Int. 2005; 96: 313-5.
52. Ubee S, Kumar M, Athmanathan N, Singh G, Vesey S. Intraoperative red blood cell salvage and autologous transfusion during open radical retropubic prostatectomy: a cost-benefit analysis. Ann R Coll Surg Engl. 2011; 93: 157-61.
53. Vagner EA, Davidov MI. [blood reinfusion during nephrectomy in patients with kidney neoplasm']. Khirurgiia. 1998: 23-7.
54. Zulim RA, Rocco M, Goodnight JE, Smith GJ, Krag DN, Schneider PD. Intraoperative autotransfusion in hepatic resection for malignancy. Is it safe? Arch Surg. 1993; 128: 206-11.
55. Xu J, Kinnear N, Johns Putra L. Safety, efficacy and cost of intra-operative cell salvage during open radical prostatectomy. Transl Androl Urol. 2021; 10(3): 1241-9.
56. Hirano Y, Miyoshi Y, Kondo Y, Okamoto K, Tanaka H. Liberal versus restrictive red blood cell transfusion strategy in sepsis or septic shock: a systematic review and metaanalysis of randomized trials. Crit Care. 2019; 23: 262.
57. Waters JH, Yazer M, Chen YF, Kloke J. Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion. 2012; 52: 2167-73.
58. Galaal K, Lopes A, Pritchard C, Barton A, Wingham J, Marques EMR, et al. Trial of intraoperative cell salvage versus transfusion in ovarian cancer (tic toc): protocol for a randomised controlled feasibility study. BMJ Open. 2018; 8: e024108.
59. Yaw PB, Sentany M, Link WJ, Wahle WM, GGlover JL. Tumor cells carried through autotransfusion. Contraindication to intraoperative blood recovery? JAMA. 1975; 231: 490-1.
60. Fruhauf NR, Dumpich O, Kaudel CP, Kasimir- Bauer S, Oldhafer KJ. Filtration of malignant cells: tumour cell depletion in an ex vivo model using a leukocyte adhesion filter. Perfusion. 2001; 16(Suppl l): 51-5.
61. Marraccini C, Merolle L, Berni P, Boito K, Tamagnini I, Kuhn E, et al. Safety of leucodepleted salvaged blood in oncological surgery: an in vitro model. Vox Sang. 2017; 112: 803-5.
62. Edelman MJ, Potter P, Mahaffey KG, Frink R, Leidich RB. The potential for reintroduction of tumor cells during intraoperative blood salvage: reduction of risk with use of the rc- 400 leukocyte depletion filter. Urology. 1996; 47: 179-81.
63. Muller M, Kuhn DF, Hinrichs B, Schindler E, Dreyer T, Hirsch C, et al. Ist die elimination von osteosarkomzellen durch .,maschinelle autotransfusion" und leukozytendepletionsfilter moglich? Anaesthesist. 1996; 45: 834-8.
64. Kongsgaard UE, Wang MY, Kvalheim G. Leucocyte depletion filter removes cancer cells in human blood. Acta Anaesthesiol Scand. 1996; 40: 118-20.
65. Futamura N, Nakanishi H, Hirose H, Nakamura S, Tatematsu M. The effect of storage on the survival of cancer cells in blood and efficient elimination of contaminating cancer cells by a leukocyte depletion filter. Am Surg. 2005; 71: 585-90.
66. Liang TB, Li DL, Liang L, Li JJ, Bai XL, Yu W, et al. Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells. Transplantation. 2008; 85: 863-9.
67. Catling S, Williams S, Freites O, Rees M, Davies C, Hopkins L. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia. 2008; 63: 1332-8.
68. Kumar N, Ahmed Q, Lee VK, Zaw AS, Goy R, Wong HK. Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery? Eur Spine J. 2016; 25: 3997-4007.
69. Perseghin P, Viganò M, Rocco G, Della Pona C, Buscemi A, Rizzi A. Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients. Vox Sang. 1997; 72: 221-4.
70. IAKH: recommendation of the interdisciplinary working group for clinical hemotherapy. https://www.iakh.de/der-einsatz-der-maschinellen- autotransfusion-in-der-onkochirurgie. html (last access 1.5.2022).
71. Klein AA, Bailey CR, Charlton AJ, Evans E, Guckian-Fisher M, McCrossan R, et al. Association of anaesthetists guidelines: cell salvage for peri-operative blood conservation 2018. Anaesthesia. 2018; 73: 1141-50.
72. Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, et al. Management of severe perioperative bleeding: guidelines from the european society of anaesthesiology: First update 2016. Eur J Anaesthesiol. 2017; 34: 332-95.
73. Leal-Noval SR, Munoz M, Asuero M, Contreras E, Garcia-Erce JA, Llau JV, et al. Spanish expert panel on alternatives to allogeneic blood T: Spanish consensus statement on alternatives to allogeneic blood transfusion -The 2013 update of the "seville document". Blood Transfus. 2013; 11: 585-610.
74. Society of Thoracic Surgeons Blood Conservation Guideline Task Force; Ferraris VA, Ferraris VA, Brown JR, Despotis GJ, Hammon JW, et al. 2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011; 91: 944-82.
75. Waters J, Dyga RM, Yazer MH. AABB guidelines for blood recovery and reinfusion in surgery and trauma: AABB; 2010.